Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Expressed Competent Cells Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Expressed Competent Cells Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Chemically Competent Cells
      • 1.3.3 Electrocompetent Cells
    • 1.4 Market Segment by Application
      • 1.4.1 Global Expressed Competent Cells Market Share by Application (2019-2025)
      • 1.4.2 Protein Expression
      • 1.4.3 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Expressed Competent Cells Market Size
      • 2.1.1 Global Expressed Competent Cells Revenue 2014-2025
      • 2.1.2 Global Expressed Competent Cells Sales 2014-2025
    • 2.2 Expressed Competent Cells Growth Rate by Regions
      • 2.2.1 Global Expressed Competent Cells Sales by Regions 2014-2019
      • 2.2.2 Global Expressed Competent Cells Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Expressed Competent Cells Sales by Manufacturers
      • 3.1.1 Expressed Competent Cells Sales by Manufacturers 2014-2019
      • 3.1.2 Expressed Competent Cells Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Expressed Competent Cells Revenue by Manufacturers (2014-2019)
      • 3.2.2 Expressed Competent Cells Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Expressed Competent Cells Market Concentration Ratio (CR5 and HHI)
    • 3.3 Expressed Competent Cells Price by Manufacturers
    • 3.4 Key Manufacturers Expressed Competent Cells Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Expressed Competent Cells Market
    • 3.6 Key Manufacturers Expressed Competent Cells Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Chemically Competent Cells Sales and Revenue (2014-2019)
      • 4.1.2 Electrocompetent Cells Sales and Revenue (2014-2019)
    • 4.2 Global Expressed Competent Cells Sales Market Share by Type
    • 4.3 Global Expressed Competent Cells Revenue Market Share by Type
    • 4.4 Expressed Competent Cells Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Expressed Competent Cells Sales by Application

    6 United States

    • 6.1 United States Expressed Competent Cells Breakdown Data by Company
    • 6.2 United States Expressed Competent Cells Breakdown Data by Type
    • 6.3 United States Expressed Competent Cells Breakdown Data by Application

    7 European Union

    • 7.1 European Union Expressed Competent Cells Breakdown Data by Company
    • 7.2 European Union Expressed Competent Cells Breakdown Data by Type
    • 7.3 European Union Expressed Competent Cells Breakdown Data by Application

    8 China

    • 8.1 China Expressed Competent Cells Breakdown Data by Company
    • 8.2 China Expressed Competent Cells Breakdown Data by Type
    • 8.3 China Expressed Competent Cells Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Expressed Competent Cells Breakdown Data by Company
    • 9.2 Rest of World Expressed Competent Cells Breakdown Data by Type
    • 9.3 Rest of World Expressed Competent Cells Breakdown Data by Application
    • 9.4 Rest of World Expressed Competent Cells Breakdown Data by Countries
      • 9.4.1 Rest of World Expressed Competent Cells Sales by Countries
      • 9.4.2 Rest of World Expressed Competent Cells Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck KGaA
      • 10.1.1 Merck KGaA Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.1.4 Expressed Competent Cells Product Introduction
      • 10.1.5 Merck KGaA Recent Development
    • 10.2 Thermo Fisher Scientific
      • 10.2.1 Thermo Fisher Scientific Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.2.4 Expressed Competent Cells Product Introduction
      • 10.2.5 Thermo Fisher Scientific Recent Development
    • 10.3 Agilent Technologies
      • 10.3.1 Agilent Technologies Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.3.4 Expressed Competent Cells Product Introduction
      • 10.3.5 Agilent Technologies Recent Development
    • 10.4 Takara Bio
      • 10.4.1 Takara Bio Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.4.4 Expressed Competent Cells Product Introduction
      • 10.4.5 Takara Bio Recent Development
    • 10.5 Promega Corporation
      • 10.5.1 Promega Corporation Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.5.4 Expressed Competent Cells Product Introduction
      • 10.5.5 Promega Corporation Recent Development
    • 10.6 Beijing TransGen Biotech
      • 10.6.1 Beijing TransGen Biotech Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.6.4 Expressed Competent Cells Product Introduction
      • 10.6.5 Beijing TransGen Biotech Recent Development
    • 10.7 GeneScript Corporation
      • 10.7.1 GeneScript Corporation Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.7.4 Expressed Competent Cells Product Introduction
      • 10.7.5 GeneScript Corporation Recent Development
    • 10.8 Yeastern Biotech
      • 10.8.1 Yeastern Biotech Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.8.4 Expressed Competent Cells Product Introduction
      • 10.8.5 Yeastern Biotech Recent Development
    • 10.9 New England Biolabs
      • 10.9.1 New England Biolabs Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.9.4 Expressed Competent Cells Product Introduction
      • 10.9.5 New England Biolabs Recent Development
    • 10.10 QIAGEN N.V.
      • 10.10.1 QIAGEN N.V. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Expressed Competent Cells
      • 10.10.4 Expressed Competent Cells Product Introduction
      • 10.10.5 QIAGEN N.V. Recent Development
    • 10.11 OriGene Technologies
    • 10.12 Lucigen
    • 10.13 Zymo Research
    • 10.14 Bio-Rad Laboratories
    • 10.15 Bioline
    • 10.16 Delphi Genetics
    • 10.17 IBA GmBH
    • 10.18 Cell Applications
    • 10.19 BioDynamics Laboratory
    • 10.20 Scarab Genomics

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Expressed Competent Cells Sales Channels
      • 11.2.2 Expressed Competent Cells Distributors
    • 11.3 Expressed Competent Cells Customers

    12 Market Forecast

    • 12.1 Global Expressed Competent Cells Sales and Revenue Forecast 2019-2025
    • 12.2 Global Expressed Competent Cells Sales Forecast by Type
    • 12.3 Global Expressed Competent Cells Sales Forecast by Application
    • 12.4 Expressed Competent Cells Forecast by Regions
      • 12.4.1 Global Expressed Competent Cells Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Expressed Competent Cells Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Expressed Competent Cells is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Expressed Competent Cells.

      This report studies the global market size of Expressed Competent Cells, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Expressed Competent Cells sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Merck KGaA
      Thermo Fisher Scientific
      Agilent Technologies
      Takara Bio
      Promega Corporation
      Beijing TransGen Biotech
      GeneScript Corporation
      Yeastern Biotech
      New England Biolabs
      QIAGEN N.V.
      OriGene Technologies
      Lucigen
      Zymo Research
      Bio-Rad Laboratories
      Bioline
      Delphi Genetics
      IBA GmBH
      Cell Applications
      BioDynamics Laboratory
      Scarab Genomics

      Market Segment by Product Type
      Chemically Competent Cells
      Electrocompetent Cells

      Market Segment by Application
      Protein Expression
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Expressed Competent Cells status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Expressed Competent Cells manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Expressed Competent Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now